- Ocular Health Section
- Research & Innovation
- Fondation Théa
Théa belongs to a select circle of pharmaceutical companies with subsidiaries at the continent’s four cardinal points. Throwback to Théa's European construction.
World Glaucoma Week (March 7-13) is a global initiative of the World Glaucoma Association (WGA) to raise awareness on glaucoma.
Théa, the leading European pharmaceutical group in ophthalmology (excluding the retina market), increases its research and clinical trials capacity by doubling its innovation space footprint at the headquarters in Clermont-Ferrand. It also promises several breakthroughs for innovation
Innovation is not Théa’s only priority. Education and the sharing of knowledge have always been an important tradition for the Chibret family. Théa supports many projects and pedagogical activities. Discover the movie
The Fondation Théa aims to promote or assist, in France and abroad, humanitarian or general interest initiatives to aid the fight against blindness and improve eye health. Discover the movie
Education and knowledge sharing have always been a tradition for the Chibret family. Théa supports numerous educational projects and activities. Among them, the Medical Library Collection.
We have always admired the extraordinary force of character of our ancestor, Paul Chibret, a young military doctor and future ophthalmologist, who, in 1870, left his home town in France to relieve human suffering in Algeria, and more specifically fight against the disease trachoma.
Théa’s human capital ensures its prosperity and constitutes its main strategic resource.
Visit Théa Careers page
Théa has its own commercial and marketing structure in the main European countries:
France, Italy, Spain, Germany, Poland, Portugal, Belgium, Netherlands, Switzerland, the United Kingdom and Ireland
and in Northern Africa (Morocco) and in South America (Mexico),as well as an exclusive sales force in some countries distributors (Algeria, Tunisia) and distributors throughout the rest of the world.